Baricitinib as Treatment for Coronavirus Disease 2019 (COVID-19): Friend or Foe of the Pancreas? Reply

• Type of Material: Article
• Authors: Boghuma K. Titanji, Emory University; Monica Farley, Emory University; Raymond Schinazi, Emory University; Vincent Marconi, Emory University
• Language: English
• Date: 2021-12-06
• Publisher: OXFORD UNIV PRESS INC
• Publication Version: Final Published Version
• Copyright Statement: Published by Oxford University Press for the Infectious Diseases Society of America 2020
• Final Published Version (URL): http://dx.doi.org/10.1093/cid/ciaa1212
• Title of Journal or Parent Work: CLINICAL INFECTIOUS DISEASES
• Volume: 73
• Issue: 11
• Start Page: E3978
• End Page: +
• Grant/Funding Information: V. M. and R. F. S. are partially funded by—Emory University Center for AIDS Research (AI050409). R. F. S. is funded in part by National Institutes of Health (NIH) grant 5-R01-MH116695.
• Keywords: Infectious Diseases; Science & Technology; Life Sciences & Biomedicine; Microbiology; Immunology
• Research Categories: Health Sciences, Immunology; Biology, Microbiology

Abstract

To the editor—In response to our recent publication in Clinical Infectious Diseases, Cerda-Contreras et al present the case of a critically ill 72-year-old woman with coronavirus disease 2019 (COVID-19) and multiple comorbidities.